Skip to main content
. 2019 Mar 7;14(3):e0213180. doi: 10.1371/journal.pone.0213180

Table 3. Chondroitin sulfate and heparan sulfate fraction in total sulfated glycosaminoglycan in urine of healthy controls, urolithiasis patients, children of control (CC) and children of urolithiasis (UC).

Control Urolithiasis CC UC
Chondroitin sulfate/Total sGAGs (%) 61.7±21.4 56.6±24.5 53.5±23.4 56.9±18.2
Heparan sulfate/Total sGAGs (%) 15.7±8.0 23.2±16.8* 15.0±8.5 22.8±7.6#

*p < 0.05 compared with Control

#p < 0.05 compared with CC